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EDITORIAL
With the death of ABC journalist
Peter Jennings during the summer from
lung cancer, apparently from smoking
over many years, the media particularly
in the United States and to some extent
in Canada as Jennings was a Canadian
by  birth,  has  seen  fit  to  extend  their
coverage  to  the  many  anti-smoking
initiatives in both countries.  While the
intent  to  highlight  the  harm  done  by
smoking was obvious, the coverage did
little to support the views of the medical
community  that  long  term  tobacco
smoking and for that matter, inhalation
of second hand tobacco smoke, is an
established risk factor for anything other
than lung cancer.
   Indeed suggestions that little or
no progress has been made in diagnosis
and treatment of this or other tobacco-
smoke  linked  cancers  seemed  a  bit
disturbing.  This  coverage  included
physicians  involved  in  clinical  anti-
smoking campaigns, the occasional basic
medical  scientist  and  epidemiologists
studying  trends  in  smoking  habits,
particularly in teenagers.  (see article by
von Ah in this issue).  Yet among these
professional  anti-smoking  groups,  an
interview with a Philip Morris executive
stood out as particularly disturbing.  This
related  to  the  continuing  belief  that
tobacco  companies  are  still  targeting
teenagers  and  younger  children  to
replenish  the  progressively  declining
numbers of adult smokers.  The specious
arguments from these officials that the
use  of  cartoon-like  characters  in
advertisements does not directly target
young  potential  smokers  seems
amazingly duplicitous. So it would seem
that  despite  multimillion  dollar
settlement  suits  against  the  tobacco
companies, little has changed in their
perception  of  risk-harm  assessments.
This  demonstration  of  the  continuing
belief of the tobacco companies that the
public accepts their statements at face
value,  even  after  decades  of
misrepresentation, is amazing for those
of us who work in the various aspect of
research related to tobacco smoke and
have  some  knowledge  of  the  well
documented harm caused by smoking.
Sadly  the  tobacco  companies’  views
probably represent the majority views of
the public at large and in many respects
is therefore very accurate. This raises the
question as to why this should be so.
Two  rationalé  come  immediately  to
mind.   Social  acceptance  of  smoking
was,  at  least  some  years  ago,
unquestioned. In many parts of the world
this situation remains.   In addition, the
detrimental health effects of smoking are
neither readily apparent nor immediate
in their demonstrability.  Indeed with the
exception  of  lung  cancer,  a  good
percentage of the public would still seem
to  view  the  issue  of  the  detrimental
effects of tobacco smoking as unproven.
Indeed  the  long  latency  of  tobacco
effects  and  in  fact  the  resiliency  of
biological model systems has become
quite clear in experiments ongoing in our
and other laboratories. This should not
be construed however to suggest that
smoking or exposure to ETS is benign
for it is very difficult in the laboratory to
emulate the in vivo exposures of many
years  to  the  complex  array  of
carcinogens  in  smoke.   Indeed  new
molecular approaches to cellular changes
induced  by  single  or  multiple
components of smoke have only begun
to  characterize  mechanisms  whereby
these  agents  may  activate  and  alter
cellular metabolic processes.2 Scott JE
New  research  into  the  many  risks
associated with tobacco smoke exposure
requires many forums for investigation,
public exposure and review. Without a
doubt, smoking induces changes at the
cellular and molecular   levels in many
organs.  From  initial  exposure  via  the
huge  surface  area  of  the  pulmonary
tissues  which  is  often  unappreciated,
circulatory  distribution  of  dozens  of
toxins has effects, largely unknown, on
many tissues, probably related to each
individual  tissue's  spectrum  of
susceptibility  and  expression  of
receptors for the numerous toxins as well
as toxin lipid solubility.  The grounds for
further research into these effects is a
very fertile area and the complexity of
these  potential  interactions  will  be
without a doubt very difficult to interpret
and controversial.
Taking on these many challenges, the
journal has identified some five areas
which will be pursued. Four of these are
already well under way, largely due to
the pioneering efforts of Dr. Longo, who
has established the scientific integrity of
this journal. This will soon be reflected
in a move to BioMed Central. Without
his efforts we could not hope to continue
further publications and our efforts to
establish  a  reputable  scientific
publication. The fifth and final area must
be approached very cautiously due to the
somewhat  controversial  and  difficult
nature of research in the area.  This is of
course  research  into  cellular  and
molecular  changes  induced  by  smoke
and  smoke  components  in  the  many
organ  systems  which  are  well
established to be influenced via direct
exposure such as the lung or through
distribution by the circulatory system.
We  hope  to  establish  this  pillar  of
biomedical  research  as  a  significant
component of our publication.  Integrity
in this and the other areas will of course
come  from  quality  publications  and
international recognition of the editorial
board on whom we will all rely heavily.
The  support  of  the  members  of  the
editorial  board  and  executive  of  the
ISPTID  is  hereby  gratefully
acknowledged.
Finally we must again acknowledge the
efforts of Dr. Daniel Longo in providing
direction and insight in the initial phases
of  development  of  the  journal.   We
would encourage all researchers in areas
related  to  smoking  epidemiology  or
biomedical application to consider the
journal for publication of their results.
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